neuroblastoma
Y-mAbs claims FDA OK for neuroblastoma drug Danyelza
Phil Taylor
antibody, Danyelza, neuroblastoma, Oncology, Y-mAbs Therapeutics
0 Comment
Taking lenient stance, NICE backs neuroblastoma drug
Richard Staines
dinutuximab alpha, EUSA Pharma, neuroblastoma, NICE
0 Comment
Body makes special case due to rarity of the disease
EUSA Pharma looks to further in-licensing to build growth
Richard Staines
cancer, EUSA Pharma, Jazz Pharmaceuticals, kidney cancer, neuroblastoma
0 Comment
EUSA Pharma approval fills gap in neuroblastoma market
Richard Staines
cancer, neuroblastoma, orphan, paediatric
0 Comment
Company can move in after United Therapeutics withdrew its product Unituxin
Brain cancer drug too expensive, says NICE
Richard Staines
Cancer Drugs Fund, neuroblastoma, NICE, United Therapeutics
0 Comment
Unituxin too costly for use in children, NICE says.